The Arimoto Group studies biologically active small molecules that contribute to human healthcare. Research in the lab is currently focused on three major areas: regulatory mechanisms of autophagy through nitric oxide signaling in the innate immune response to bacterial infection; development of antibacterial agents against vancomycin-resistant strains; and organic synthesis of natural products. We utilize diverse chemical and biological techniques including eukaryotic and bacterial cell cultures, biochemistry, molecular biology, organic synthesis, and nuclear magnetic resonance spectroscopy.